Vitamin D and HbA1c Levels in Diabetic Patients With CKD
NCT ID: NCT02906319
Last Updated: 2016-09-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2015-09-30
2016-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vitamin D Inadequacy on Postprandial Glucose in Type 2 Diabetes Mellitus
NCT01488916
Vitamin D Inadequacy is Associated With Incidence of Type 2 Diabetes
NCT01508481
Impact of Vitamin D on Diabetic Kidney Disease in African Americans
NCT01214356
Effects of Vitamin D Supplementation on Glucose Metabolism in Women With Former Gestational Diabetes Mellitus
NCT01992133
Correlation of Vitamin D Levels in Early Pregnancy With Gestational Diabetes and Pregnancy Outcomes
NCT05212519
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Serum 25(OH)D levels were determined by using direct chemiluminesent immunoassay (ADVIA Centaur XP; Siemens Healthcare Diagnostics, Tarrytown, New York, USA). Serum HbA1c levels were determined using high-pressure liquid chromatography (Variantâ„¢ II Turbo; Bio-Rad, Hercules, California, USA).
Data collected will be analyzed using Statistical Package for Social Sciences SPSS version 23.0 for Windows, version 23.0 (IBM Corp., Armonk, New York, USA).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age ≥ 18 years old
* able to provide informed consent
Exclusion Criteria
* autoimmune diseases
* malignancies
* on immunosuppressive therapy
* on vitamin D supplements
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Malaya
OTHER
Malaysian Society of Nephrology
UNKNOWN
Ng Yong Muh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ng Yong Muh
Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yong Muh Ng, MMed
Role: PRINCIPAL_INVESTIGATOR
University of Malaya
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201412-878
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.